Inventor · disambiguated record
Pamela T. Manning
Also filed as: MANNING PAMELA T
19 granted patents·19 pending applications·288 citations·filing 1999–2022
95Inventor score
Top patents by PatentIndex Score
38 records- 0197US10259873B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·21 cites·4 claims
- 0297US9518117B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·23 cites·6 claims
- 0397US9518116B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2015·Granted Dec 13, 2016·27 cites·9 claims
- 0497US9221908B2Therapeutic CD47 antibodiesVASCULOX INC·Filed 2013·Granted Dec 29, 2015·46 cites·5 claims
- 0594US7196118B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2005·Granted Mar 27, 2007·24 cites·2 claims
- 0693US6586474B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2001·Granted Jul 1, 2003·46 cites·108 claims
- 0791US10239945B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Mar 26, 2019·13 cites·14 claims
- 0890US10844124B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Nov 24, 2020·6 cites·13 claims
- 0990US10669336B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 2, 2020·4 cites·2 claims
- 1086US6914158B2Amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2004·Granted Jul 5, 2005·17 cites·14 claims
- 1185US10676524B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Jun 9, 2020·2 cites·4 claims
- 1285US7012098B2Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancersPHARMACIA CORP·Filed 2001·Granted Mar 14, 2006·29 cites·5 claims
- 1381US2023192849A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1478US7102013B2Methods of making amidino compounds useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2002·Granted Sep 5, 2006·8 cites·18 claims
- 1577US6465686B2Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2001·Granted Oct 15, 2002·10 cites·106 claims
- 1676US6465518B2Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitorsPHARMACIA CORP·Filed 2001·Granted Oct 15, 2002·9 cites·76 claims
- 1770US11292834B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Apr 5, 2022·0 cites·6 claims
- 1865US2021079091A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1964US11692035B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Jul 4, 2023·0 cites·17 claims
- 2064US2019112373A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2164US2021070865A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2261US2014363442A1Therapeutic cd47 antibodiesFRAZIER WILLIAM A·Filed 2014·Application pending·0 cites
- 2360US2018142019A1Therapeutic cd47 antibodiesTIOMA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2454US2005203082A1Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agentsFiled 2004·Application pending·0 cites
- 2553US2022313819A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 2653US2005113409A1Method for the prevention or treatment of pain, inflammation and inflammation-related disorders with a Cox-2 selective inhibitor in combination with a nitric oxide-donating agent and compositions therewithPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2751US2015274826A1Therapeutic cd47 antibodiesVASCULOX INC·Filed 2015·Application pending·0 cites
- 2848US2021324075A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2945US2004143017A1Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitorsFiled 2003·Application pending·0 cites
- 3044US2004087653A1Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions thereforFiled 2003·Application pending·0 cites
- 3144US2004077639A1Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitorFiled 2003·Application pending·0 cites
- 3244US2021395831A1Biomarkers to improve efficacy of cancer immunotherapyARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 3343US2019309066A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 3440US6586471B1Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitorsSEARLE & CO·Filed 2001·Granted Jul 1, 2003·0 cites·77 claims
- 3540US2004127569A1Methods for treatment and prevention of gastrointestinal conditionsFiled 2003·Application pending·0 cites
- 3638US6653350B1Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitorsSEARLE & CO·Filed 1999·Granted Nov 25, 2003·3 cites·12 claims
- 3737US2003119826A1Neuroprotective treatment methods using selective iNOS inhibitorsPHARMACIA CORP·Filed 2001·Application pending·0 cites
- 3836US2003109522A1Ophthalmologic treatment methods using selective iNOS inhibitorsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pamela T. Manning files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →